AOC3 and inflammatory bowel disease: Blocking of VAP-1 significantly inhibited the binding of all leukocyte subsets to joint vessels, suggesting an important role of VAP-1 in intestinal inflammation and the development of reactive arthritis in inflammatory bowel disease [37].